-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $136 at Truist Securities
-
-
-
-
-
-
-
Canaccord Starts Kymera Therapeutics (KYMR) at Buy
-
-
-
-
-
-
-
Kymera presents atopic dermatitis trial data at dermatology meeting
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) Misses Q4 EPS by 18c
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $120 at Mizuho
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $127 at Morgan Stanley
-
-
-
-
-
-
-
Kymera Therapeutics' (KYMR) Ph2b AD Solidifying First-in-Class Position - Stifel
-
445,864 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

